230P Pathologic response to neoadjuvant therapy in HER2 positive/oestrogen receptor positive breast cancer patients

Autor:	C. Canosa Morales, A. Rodriguez Galindo, A. Gasol Cudos, Serafin Morales, J. Melé Olivé, A. Serrate Lopez, A. Velasco Sanchez
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry medicine.medical_treatment Hematology medicine.disease Breast cancer Internal medicine medicine Pathologic Response Oestrogen receptor business Neoadjuvant therapy
Zdroj:	Annals of Oncology. 31:S333
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.351
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0f3a1c7bae02de563a102b3b80bcdb5b https://doi.org/10.1016/j.annonc.2020.08.351 Zobrazit plný text záznamu